Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Protease anticorps

Cet anticorps anti-Protease Polyclonal Lapin (ABIN284976) détecte spécifiquement Protease dans ELISA et WB. L’anticorps est réactif avec des échantillons de Human Immunodeficiency Virus (HIV).
N° du produit ABIN284976
281,49 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 13 à 17 jours ouvrables

Aperçu rapide pour Protease anticorps (ABIN284976)

Antigène

Protease

Reactivité

  • 1
  • 1
Human Immunodeficiency Virus (HIV)

Hôte

  • 2
Lapin

Clonalité

  • 2
Polyclonal

Conjugué

  • 2
Inconjugué

Application

  • 2
  • 2
  • 2
  • 1
  • 1
ELISA, Western Blotting (WB)
  • Purification

    Purified

    Pureté

    > 95 % pure

    Immunogène

    HIV1 protease antibody was raised in rabbit using full length recombinant protease (HIV-1) as the immunogen.

    Isotype

    IgG
  • Indications d'application

    ELISA: 1:500-1:1,000, WB: 1:500-1:1,000
    Optimal conditions should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Frozen

    Concentration

    Lot specific

    Buffer

    Supplied frozen in PBS.

    Conseil sur la manipulation

    Avoid repeated freeze/thaw cycles.
    Dilute only prior to immediate use.

    Stock

    4 °C/-20 °C

    Stockage commentaire

    Store at 4 °C until reconstitution. Following reconstitution aliquot and freeze at -70 °C for long term storage.
  • Antigène

    Protease

    Classe de substances

    Viral Protein

    Sujet

    HIV-1 protease (HIV PR) is a retroviral aspartyl protease that is essential for the life-cycle of HIV, the retrovirus that causes AIDS. HIV PR cleaves newly synthesized polyproteins at the appropriate places to create the mature protein components of an infectious HIV virion. Without effective HIV PR, HIV virions remain uninfectious. Thus, mutation of HIV PR’s active site or inhibition of its activity disrupts HIV’s ability to replicate and infect additional cells, making HIV PR inhibition the subject of much pharmaceutical research.
Vous êtes ici:
Chat with us!